These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8244820)

  • 41. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha.
    Kawakita N; Seki S; Yanai A; Sakaguchi H; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S14-20. PubMed ID: 1374217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Canine mast cell tumors: a comparison of staining techniques.
    Simoes JP; Schoning P
    J Vet Diagn Invest; 1994 Oct; 6(4):458-65. PubMed ID: 7532014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
    Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
    Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
    van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
    Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P-selectin expression in canine cutaneous inflammatory diseases and mast cell tumors.
    Chénier S; Doré M
    Vet Pathol; 1998 Mar; 35(2):85-93. PubMed ID: 9539361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime.
    Azuma C; Raleigh JA; Thrall DE
    Radiat Res; 1997 Jul; 148(1):35-42. PubMed ID: 9216616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canine malignant mammary tumours. I. Sarcomas.
    Misdorp W; Cotchin E; Hampe JF; Jabara AG; von Sandersleben J
    Vet Pathol; 1971; 8(2):99-117. PubMed ID: 4367432
    [No Abstract]   [Full Text] [Related]  

  • 48. Cellular proliferative and telomerase activity in canine mammary gland tumors.
    Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
    Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning.
    Thrall DE; Rosner GL; Azuma C; McEntee MC; Raleigh JA
    Radiother Oncol; 1997 Aug; 44(2):171-6. PubMed ID: 9288846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
    Kleiter MM; Thrall DE; Malarkey DE; Ji X; Lee DY; Chou SC; Raleigh JA
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):592-602. PubMed ID: 16289910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
    Varia MA; Calkins-Adams DP; Rinker LH; Kennedy AS; Novotny DB; Fowler WC; Raleigh JA
    Gynecol Oncol; 1998 Nov; 71(2):270-7. PubMed ID: 9826471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
    Golouh R; Bracko M; Novak J
    Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis.
    Siitonen SM; Isola JJ; Rantala IS; Helin HJ
    Am J Clin Pathol; 1993 Mar; 99(3):226-31. PubMed ID: 8095363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma.
    Kung MBJ; Poirier VJ; Dennis MM; Vail DM; Straw RC
    Vet Comp Oncol; 2016 Dec; 14(4):e135-e145. PubMed ID: 25393921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
    Affolter VK; Moore PF
    Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
    Oshiro Y; Fukuda T; Tsuneyoshi M
    Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.
    Ljungkvist AS; Bussink J; Rijken PF; Kaanders JH; van der Kogel AJ; Denekamp J
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):215-28. PubMed ID: 12182995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
    Smedley RC; Lamoureux J; Sledge DG; Kiupel M
    Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A subcutaneous mass on the neck of a horse.
    Brown HM; Cuttino E; LeRoy BE
    Vet Clin Pathol; 2007 Mar; 36(1):109-13. PubMed ID: 17311206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.